Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Radiation Protection Dosimetry|May 8, 2015
Scavenging of hydroxyl radicals generated in human plasma following X-ray irradiationYoichiro Hosokawa, Tomoaki SanoOncology Reports|January 1, 2016
Genetic network profiles associated with established resistance to ionizing radiation in acute promyelocytic leukemia cells and their extracellular vesiclesSatoru Monzen, Mitsuru Chiba, Yoichiro HosokawaInternational Journal of Radiation Biology|December 15, 2025
Stromal-derived high-molecular-weight hyaluronan mediates radioresistance in the prostate cancer microenvironmentRyo Saga, Kenta Iwamori, Yoichiro HosokawaComputers in Biology and Medicine|May 12, 2026
Prediction of tumor control probability in prostate cancer radiotherapy using a biophysical model incorporating cancer stem cell and hypoxiaRyo Saga, Kenta Iwamori, Yusuke Matsuya, et al.Japanese Journal of Radiology|January 30, 2010
Measuring the inequalities in radiotherapy health resources in Japan: comparison of the Hokkaido-Tohoku and Tokyo districtsHisateru Ohba, Masakazu Narumi, Yoichiro Hosokawa, et al.Leukemia Research|June 19, 2013
Acute promyelocytic leukemia mutated to radioresistance suppressed monocyte lineage differentiation by phorbol 12-myristate 13-acetateSatoru Monzen, Kodai Takimura, Ikuo Kashiwakura, et al.International Journal of Radiation Biology|February 3, 2025
Evaluation of the influence of radiation-induced cohort effect in cell populations receiving different dosesShingo Terashima, Ryota Tatemura, Wataru Saito, et al.Oncology Reports|May 12, 2012
Regulation of DNA damage response and cell cycle in radiation-resistant HL60 myeloid leukemia cellsMasaharu Hazawa, Yoichiro Hosokawa, Satoru Monzen, et al.Nihon Hoshasen Gijutsu Gakkai Zasshi|May 22, 2018
[Screening for Biological Marker of Dose-optimization in Cancer Radiotherapy]Tatsuya Ueno, Satoru Monzen, Mitsuru Chiba, et al.Life (Basel, Switzerland)|December 24, 2021
The Effect of High-Dose-Rate Pulsed Radiation on the Survival of Clinically Relevant Radioresistant CellsShingo Terashima, Hironori Yoshino, Yoshikazu Kuwahara, et al.Pageof 7